ニューヨークにおけるB細胞リンパ腫の臨床試験
ニューヨーク内の拠点で、B細胞リンパ腫に関する21件の研究が参加者を募集しています。
ニューヨーク内の都市
公式研究テキスト（英語）
A Study to Investigate the Efficacy and Safety of Sonrotoclax Plus Zanubrutinib Compared With Placebo Plus Zanubrutinib in Adults With Relapsed/Refractory Mantle Cell Lymphoma (CELESTIAL-RRMCL)
- Memorial Sloan Kettering Cancer Center Mskcc, New York
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/28更新 · NCT06742996A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )
- New York University (NYU) Clinical Cancer Center, New York
- Weill Cornell Medicine, New York
- David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center, New York
被験者募集中第1相
18歳以上 · 全性別 · 2026/09/22更新 · NCT07101328A Study of CD19 Targeted CAR T Cell Therapy in Pediatric Patients With Relapsed or Refractory B Cell Acute Lymphoblastic Leukemia (B ALL) and Aggressive Mature B-cell Non-Hodgkin Lymphoma (B NHL)
- The Mount Sinai Hospital, New York
被験者募集中第1相
0歳〜18歳 · 全性別 · 2026/09/16更新 · NCT06173518Surovatamig (AZD0486) as Monotherapy in Participants With Relapsed/Refractory (R/R) B-cell NHL
- Research Site, New York
被験者募集中第2相
18歳以上 · 全性別 · 2026/09/11更新 · NCT06526793A Study to Investigate Safety and Effectiveness of Tacabrutideg (BGB-16673) in Combination With Other Agents in Participants With Relapsed or Refractory B-Cell Malignancies
- Icahn School of Medicine At Mount Sinai, New York
- Columbia University Medical Center, New York
- Weill Cornell Medical College Newyork Presbyterian Hospital, New York
- 他2件
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/09/11更新 · NCT06634589Testing the Combination of Nivolumab and ASTX727 for Relapsed or Refractory B-Cell Lymphoma
- NYU Langone Hospital - Long Island, Mineola
- Laura and Isaac Perlmutter Cancer Center at NYU Langone, New York
被験者募集中第1相
18歳以上 · 全性別 · 2026/09/10更新 · NCT05272384A Study of AZD0486 Monotherapy or in Combination With Other Anti-Cancer Agents for Mature B-Cell Malignancies
- Research Site, New York
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/09/08更新 · NCT06564038A Study of ARV-393 in Relapsed/Refractory Non-Hodgkin Lymphoma.
- Clinical Trial Site, New York
- Clinical Trial Site, New York
被験者募集中第1相
18歳以上 · 全性別 · 2026/09/04更新 · NCT06393738A Phase I/II Study of AZD4512 Monotherapy or in Combination With Anticancer Agents in Participants With Relapsed/Refractory B-cell Non-Hodgkin Lymphoma
- Research Site, New York
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/08/28更新 · NCT07123454A Study of ARC-02 in B-cell NHL
- NYU Langone, New York
被験者募集中第1相
18歳以上 · 全性別 · 2026/08/26更新 · NCT07691606Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma
- Roswell Park Comprehensive Cancer Center, Buffalo
- David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center, New York
- Montefiore Medical Center, The Bronx
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/08/25更新 · NCT05826535A First-in-Human Trial of DS3790a in Participants With Hematological Malignancies
- Research Site, New York
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/08/24更新 · NCT07220616A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy
- Roswell Park Comprehensive Cancer Center, Buffalo
被験者募集中第3相
18歳以上 · 全性別 · 2026/08/04更新 · NCT07188558DALY II USA/ MB-CART2019.1 for DLBCL
- Memorial Sloan Kettering Cancer Center, New York
被験者募集中第2相
18歳以上 · 全性別 · 2026/07/13更新 · NCT04792489A Phase 1/2 Study of STP938 (Dencatistat) for Adult Subjects With Relapsed/Refractory B-Cell and T-Cell Lymphomas
- Memorial Sloan Kettering, New York
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/06/16更新 · NCT05463263Defining ctDNA Metrics in Posttransplant Lymphoproliferative Disorder (PTLD)
- Columbia University Irving Medical Center, New York
被験者募集中第2相
15歳以上 · 全性別 · 2026/05/27更新 · NCT06954805Autologous Stem Cell Transplant Followed by Polatuzumab Vedotin in Patients With B-cell Non-Hodgkin and Hodgkin Lymphoma
- New York Medical Center, Valhalla
被験者募集中第1/2相
12歳〜70歳 · 全性別 · 2026/04/15更新 · NCT04491370Study of CAR-T Therapy in Older Patients
- Memorial Sloan Kettering Cancer Center, New York
被験者募集中観察研究
60歳以上 · 全性別 · 2026/04/07更新 · NCT04300998ctDNA-guided Therapy Optimization in Newly Diagnosed DLBCL
- Columbia University, New York
被験者募集中
18歳以上 · 全性別 · 2026/01/23更新 · NCT06693830Study of a Communication Training Intervention for Large B-Cell Lymphoma Providers
- Memorial Sloan Kettering Cancer Center (All protocol activities), New York
- NEW YORK PRESBYTERIAN HOSPITAL (Data Collection Only), New York
被験者募集中
18歳以上 · 全性別 · 2025/10/09更新 · NCT05940272Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies
- Children's Hospital New York-Presbyterian, New York
- Memorial Sloan Kettering Cancer Center, New York
被験者募集中第1相
1歳〜21歳 · 全性別 · 2024/12/06更新 · NCT05476770ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。